Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 105,200 | 58,900 | 32,500 | -1,300 | 157,600 |
| Depreciation Amortization | 212,000 | 157,900 | 104,800 | 52,600 | 204,500 |
| Income taxes - deferred | 6,600 | -7,700 | -500 | 100 | -11,800 |
| Accounts receivable | -4,200 | 71,100 | 57,300 | 90,400 | -12,900 |
| Accounts payable and accrued liabilities | -200 | -53,900 | 1,300 | -25,900 | 2,000 |
| Other Working Capital | -42,900 | -87,400 | 9,100 | 16,700 | -5,000 |
| Other Operating Activity | 72,600 | 46,100 | 8,400 | -4,600 | 12,500 |
| Operating Cash Flow | $349,100 | $185,000 | $212,900 | $128,000 | $346,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -155,100 | -95,100 | -55,800 | -27,400 | -104,800 |
| Net Acquisitions | -4,000 | -3,400 | -1,100 | N/A | -200,600 |
| Sale Of Investment | 6,000 | 6,000 | 6,000 | 2,300 | 46,800 |
| Other Investing Activity | 2,700 | 2,700 | 2,700 | -100 | 0 |
| Investing Cash Flow | $-150,400 | $-89,800 | $-48,200 | $-25,200 | $-258,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 745,300 | 775,000 | 762,100 | 153,500 | 476,300 |
| Debt Repayment | -428,000 | -784,200 | -431,900 | -7,200 | N/A |
| Common Stock Issued | 100 | 100 | 100 | N/A | 1,300 |
| Common Stock Repurchased | N/A | N/A | N/A | -3,800 | N/A |
| Dividend Paid | -294,800 | -104,200 | -69,900 | -35,500 | -132,200 |
| Other Financing Activity | -355,100 | -18,800 | -350,700 | -14,400 | -262,300 |
| Financing Cash Flow | $-332,500 | $-132,100 | $-90,300 | $92,600 | $83,100 |
| Beginning Cash Position | 280,900 | 280,900 | 280,900 | 280,900 | 109,500 |
| End Cash Position | 147,100 | 244,000 | 355,300 | 476,300 | 280,900 |
| Net Cash Flow | $-133,800 | $-36,900 | $74,400 | $195,400 | $171,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 349,100 | 185,000 | 212,900 | 128,000 | 346,900 |
| Capital Expenditure | -156,800 | -96,800 | -57,500 | -29,100 | -112,100 |
| Free Cash Flow | 192,300 | 88,200 | 155,400 | 98,900 | 234,800 |